Cancer patients previously fully covered by MediSave, MediShield Life may need to pay out of pocket

Since September, cancer treatment claims have been split – with separate claim limits for drugs and services. PHOTO ILLUSTRATION: PEXELS
New: Gift this subscriber-only story to your friends and family

SINGAPORE – Ms W was diagnosed with third-stage ovarian cancer in October 2020 and is being treated at the National University Cancer Institute as a subsidised patient.

Her treatment cost was fully covered by national insurance scheme MediShield Life and national medical savings scheme MediSave, until December 2022, when she had to top up $268.50 in cash. This came as a shock.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.